News Headlines Article

Drug Pricing ‘Tantamount to Greed’ Lawmaker Says
HealthLeaders Media

Calling Sovaldi, a high-priced drug for hepatitis C, “the poster child for high Medicare Part D drug prices,” Rep. Henry Waxman (D-CA) Wednesday urged Congress to pass several bills that would ease the prescription price burden on seniors, taxpayers, and the Medicare trust fund.

Made by Gilead Sciences, Sovaldi costs $84,000 for a 12-week course of treatment. “Why are they charging that? Because they have a monopoly and they can charge whatever they want,” Waxman said.